Using the XS Toolbox to Optimize Strain Design and Development for Efficient Microbial GMP Production

Upstream-Lonza1
No single strain or vector is capable of being the best expression option for all types of biopharmaceuticals. The XS System™ ultimately decreases the time of strain screening and design to enable the fast creation of a valuable production strain and efficient cGMP process.

Speaker:
Joachim Klein, Head of Microbial Innovation & Strain Development, Lonza Bioscience

Listen to the Audio Cast

Leave a Reply